These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34454807)

  • 41. Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010).
    Hashimoto T; Tsukamoto S; Murofushi K; Ito Y; Hirano H; Tsukada Y; Sasaki K; Mizusawa J; Fukuda H; Takashima A; Kanemitsu Y
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 37931233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
    Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB
    JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Probe-Based Confocal Laser Endomicroscopy (pCLE) in the Diagnosis of Sustained Clinical Complete Response Under Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Adenocarcinoma: a Score Validation.
    Safatle-Ribeiro AV; Ribeiro U; Lata J; Baba ER; Lenz L; da Costa Martins B; Kawaguti F; Moura RN; Pennacchi C; Gusmon C; de Lima MS; de Paulo GA; Nahas CS; Marques CF; Imperiale AR; Cotti GC; Maluf-Filho F; Nahas SC
    J Gastrointest Surg; 2023 Sep; 27(9):1903-1912. PubMed ID: 37291428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
    Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
    Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Definitive Chemoradiotherapy ("Watch-and-Wait" Approach).
    Goodman KA
    Semin Radiat Oncol; 2016 Jul; 26(3):205-10. PubMed ID: 27238472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Marchegiani F; Palatucci V; Capelli G; Guerrieri M; Belluco C; Rega D; Morpurgo E; Coco C; Restivo A; De Franciscis S; Aschele C; Perin A; Bonomo M; Muratore A; Spinelli A; Ramuscello S; Bergamo F; Montesi G; Spolverato G; Del Bianco P; Gambacorta MA; Delrio P; Pucciarelli S
    Ann Surg Oncol; 2022 Mar; 29(3):1880-1889. PubMed ID: 34855063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
    Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy.
    Yu G; Lu W; Jiao Z; Qiao J; Ma S; Liu X
    World J Surg Oncol; 2021 Oct; 19(1):305. PubMed ID: 34663341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
    Habr-Gama A; Gama-Rodrigues J; São Julião GP; Proscurshim I; Sabbagh C; Lynn PB; Perez RO
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):822-8. PubMed ID: 24495589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Particular aspects of treating rectal cancer: The watch and wait approach.
    Draghici DA; Stoian AR; Porojan VA; David OI; Bedereag Ş; Ciuhu AN; Haidar A; Creţoiu D; Condrat CE; Grigorean VT
    J Cancer Res Ther; 2023; 19(2):461-469. PubMed ID: 37006080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 52. The Cost-effectiveness of Watch and Wait for Rectal Cancer.
    Bibi S; Edilbe MW; Rao C
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):132-137. PubMed ID: 36266161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protocol for a national audit of the watch-and-wait approach in patients with rectal cancer in Aotearoa New Zealand: The ACCORD study.
    STRATA Collaborative
    Colorectal Dis; 2024 Feb; 26(2):371-379. PubMed ID: 38124235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
    Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
    Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Thoughts on the watch and wait strategy of patients with rectal cancer after neoadjuvant therapy].
    Wen RB; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):230-236. PubMed ID: 32192300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis.
    Zhao GH; Deng L; Ye DM; Wang WH; Yan Y; Yu T
    World J Surg Oncol; 2020 Aug; 18(1):232. PubMed ID: 32862826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Watch and wait approach in rectal cancer: Current controversies and future directions.
    López-Campos F; Martín-Martín M; Fornell-Pérez R; García-Pérez JC; Die-Trill J; Fuentes-Mateos R; López-Durán S; Domínguez-Rullán J; Ferreiro R; Riquelme-Oliveira A; Hervás-Morón A; Couñago F
    World J Gastroenterol; 2020 Aug; 26(29):4218-4239. PubMed ID: 32848330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis.
    Li J; Ma Y; Wen L; Zhang G; Yao X
    Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.